Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter and full-year ended Dec. 31, 2024.

ZUG, Switzerland and BOSTON, Feb. 11, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious ...

The Baseball Hall of Fame announced on Monday that Billy Wagner would be inducted with a Houston Astros' logo on his plaque. While this isn't a surprise — Wagner expressed that he would like to be ...

Revenue for the fourth quarter and full year 2024 was $47.5 million and $179.0 million, respectively. The MRD business, which contributed 85% of revenue in the fourth quarter and 81% of revenue in the ...

Average Revenue Per Daily Active User (“ARPDAU”) for the Company’s social casino/free-to-play games increased to $1.30 in the fourth quarter of 2024 from $1.24 in the fourth quarter of 2023 and was ...

Live updates and the latest news as Trump prepares to impose reciprocal tariffs and his intelligence chief nominee Tulsi ...

Complete financial results, and outlook for the first quarter of 2025, can be found in our shareholder letter on the Investor ...

Shares of Shopify ( SHOP.TO ) ( SHOP) closed the trading day up three per cent on Tuesday, after the company posted quarterly ...